Impairment in verbal memory observed in first episode psychosis patients with persistent negative symptoms

Schizophrenia Research

Volumn 147, Issue 2-3, 2013, Pages 223-229

  Hovington, Cindy L ^a,b   Bodnar, Michael ^a   Joober, Ridha ^a,c   Malla, Ashok K ^a,b,c   Lepage, Martin ^a,b,c  

^a DOUGLAS MENTAL HEALTH UNIVERSITY INSTITUTE   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

First episode psychosis; Negative symptoms; Persistent negative symptoms; Verbal memory

Indexed keywords

HALOPERIDOL; OLANZAPINE; PALIPERIDONE; QUETIAPINE; RISPERIDONE; ZIPRASIDONE;

ADULT; ARTICLE; CALGARY DEPRESSION SCALE; CONTROLLED STUDY; DEPRESSION; DISEASE DURATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEMORY DISORDER; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; NEGATIVE SYNDROME; NEUROCOGNITIVE TEST; NEUROLOGIC EXAMINATION; POSITIVE SYNDROME; PRIORITY JOURNAL; PSYCHOLOGIC ASSESSMENT; PSYCHOSIS; RATING SCALE; SCALE FOR THE ASSESSMENT OF NEGATIVE SYMPTOMS; SCALE FOR THE ASSESSMENT OF POSITIVE SYMPTOMS; SCHIZOPHRENIA; SOCIAL AND OCCUPATIONAL FUNCTIONING ASSESSMENT SCALE; SYMPTOM; VERBAL MEMORY; VISUAL MEMORY; WORKING MEMORY;

ADOLESCENT; ADULT; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MEMORY DISORDERS; NEUROPSYCHOLOGICAL TESTS; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTIC DISORDERS; RETROSPECTIVE STUDIES; TIME FACTORS; VERBAL LEARNING; YOUNG ADULT;

EID: 84878972111     PISSN: 09209964     EISSN: 15732509     Source Type: Journal    
DOI: 10.1016/j.schres.2013.04.006     Document Type: Article

References (87)

1. Addington D., Addington J., Maticka-Tyndale E. Assessing depression in schizophrenia: the Calgary Depression Scale. Br. J. Psychiatry 1993, (22):39-44.
2. Albus M., Hubmann W., Scherer J., Dreikorn B., Hecht S., Sobizack N., Mohr F. A prospective 2-year follow-up study of neurocognitive functioning in patients with first-episode schizophrenia. Eur. Arch. Psychiatry Clin. Neurosci. 2002, 252(6):262-267.
3. Aleman A., Hijman R., de Haan E.H.F., Kahn R.S. Memory impairment in schizophrenia: a meta-analysis. Am. J. Psychiatry 1999, 156(9):1358-1366.
4. Anderson J.E., Wible C.G., McCarley R.W., Jakab M., Kasai K., Shenton M.E. An MRI study of temporal lobe abnormalities and negative symptoms in chronic schizophrenia. Schizophr. Res. 2002, 58(2-3):123-134.
5. Andreasen N.C. Scale for the Assessment of Positive Symptoms (SAPS) 1983, University of Iowa, Iowa City.
6. Andreasen N.C. Modified Scale for the Assessment of Negative Symptoms (SANS) 1984, University of Iowa, Iowa City.
7. Andreasen N.C. The Scale for the Assessment of Negative Symptoms (SANS): conceptual and theoretical foundations. Br. J. Psychiatry 1989, (7):49-58.
8. Baare W.F., Hulshoff Pol H.E., Hijman R., Mali W.P., Viergever M.A., Kahn R.S. Volumetric analysis of frontal lobe regions in schizophrenia: relation to cognitive function and symptomatology. Biol. Psychiatry 1999, 45(12):1597-1605.
9. Becker H.E., Nieman D.H., Wiltink S., Dingemans P.M., de Fliert J.R.V., Velthorst E., de Haan L., van Amelsvoort T.A., Linszen D.H. Neurocognitive functioning before and after the first psychotic episode: does psychosis result in cognitive deterioration?. Psychol. Med. 2010, 40(10):1599-1606.
10. Bell M.D., Mishara A.L. Does negative symptom change relate to neurocognitive change in schizophrenia? Implications for targeted treatments. Schizophr. Res. 2006, 81(1):17-27.
11. Benoit A., Bodnar M., Malla A.K., Joober R., Lepage M. The structural neural substrates of persistent negative symptoms in first-episode of non-affective psychosis: a voxel-based morphometry study. Front. Psychiatry 2012, 3:42.
12. Bilder R.M., Goldman R.S., Robinson D., Reiter G., Bell L., Bates J.A., Pappadopulos E., Willson D.F., Alvir J.M.J., Woerner M.G., Geisler S., Kane J.M., Lieberman J.A. Neuropsychology of first-episode schizophrenia: initial characterization and clinical correlates. Am. J. Psychiatry 2000, 157(4):549-559.
13. Blanchard J.J., Cohen A.S. The structure of negative symptoms within schizophrenia: implications for assessment. Schizophr. Bull. 2006, 32(2):238-245.
14. Bodnar M., Malla A., Joober R., Lepage M. Cognitive markers of short-term clinical outcome in first-episode psychosis. Br. J. Psychiatry 2008, 193(4):297-304.
15. Bodnar M., Achim A.M., Malla A.K., Joober R., Benoit A., Lepage M. Functional magnetic resonance imaging correlates of memory encoding in relation to achieving remission in first-episode schizophrenia. Br. J. Psychiatry 2012, 200(4):300-307.
16. Bonner-Jackson A., Grossman L.S., Harrow M., Rosen C. Neurocognition in schizophrenia: a 20-year multi-follow-up of the course of processing speed and stored knowledge. Compr. Psychiatry 2010, 51(5):471-479.
17. Bowie C.R., Harvey P.D. Cognition in schizophrenia: impairments, determinants, and functional importance. Psychiatr. Clin. N. Am. 2005, 28(3):613-633. (626).
18. Bozikas V.P., Andreou C. Longitudinal studies of cognition in first episode psychosis: a systematic review of the literature. Aust. N. Z. J. Psychiatry 2011, 45(2):93-108.
19. Bozikas V.P., Kosmidis M.H., Kioperlidou K., Karavatos A. Relationship between psychopathology and cognitive functioning in schizophrenia. Compr. Psychiatry 2004, 45(5):392-400.
20. Brewer W.J., Francey S.M., Wood S.J., Jackson H.J., Pantelis C., Phillips L.J., Yung A.R., Anderson V.A., McGorry P.D. Memory impairments identified in people at ultra-high risk for psychosis who later develop first-episode psychosis. Am. J. Psychiatry 2005, 162(1):71-78.
21. Brinkenkamp R., Zilmer E. The d2 Test of Attention Hogrefe & Huber Publishers 1998.
22. Buchanan R.W. Persistent negative symptoms in schizophrenia: an overview. Schizophr. Bull. 2007, 33(4):1013-1022.
23. Buchy L., Bodnar M., Malla A., Joober R., Lepage M. A 12-month outcome study of insight and symptom change in first-episode psychosis. Early Interv. Psychiatry 2010, 4(1):79-88.
24. Cannon-Spoor H.E., Potkin S.G., Wyatt R.J. Measurement of premorbid adjustment in chronic schizophrenia. Schizophr. Bull. 1982, 8(3):470-484.
25. Censits D.M., Ragland J.D., Gur R.C., Gur R.E. Neuropsychological evidence supporting a neurodevelopmental model of schizophrenia: a longitudinal study. Schizophr. Res. 1997, 24(3):289-298.
26. Chang W.C., Hui C.L., Tang J.Y., Wong G.H., Lam M.M., Chan S.K., Chen E.Y. Persistent negative symptoms in first-episode schizophrenia: a prospective three-year follow-up study. Schizophr. Res. 2011, 133(1-3):22-28.
27. Chouinard G., Margolese H.C. Manual for the Extrapyramidal Symptom Rating Scale (ESRS). Schizophr. Res. 2005, 76(2-3):247-265.
28. Corcoran R., Mercer G., Frith C.D. Schizophrenia, symptomatology and social inference: investigating "theory of mind" in people with schizophrenia. Schizophr. Res. 1995, 17(1):5-13.
29. Edwards J., McGorry P.D., Waddell F.M., Harrigan S.M. Enduring negative symptoms in first-episode psychosis: comparison of six methods using follow-up data. Schizophr. Res. 1999, 40(2):147-158.
30. First M.B., Spitzer R.L., Gibbon M., Williams J.B.W. Structured Clinical Interview for DSM-IV Axis I Disorders, Patient Edition (SCID-I/P & SCID-I/NP), Version 2 1998, New York Psychiatric Institute, Biometrics Research, New York.
31. Fitzgerald D., Lucas S., Redoblado M.A., Winter V., Brennan J., Anderson J., Harris A. Cognitive functioning in young people with first episode psychosis: relationship to diagnosis and clinical characteristics. Aust. N. Z. J. Psychiatry 2004, 38(7):501-510.
32. Foussias G., Remington G. Negative symptoms in schizophrenia: avolition and Occam's razor. Schizophr. Bull. 2010, 36(2):359-369.
33. Fridberg D.J., Brenner A., Lysaker P.H. Verbal memory intrusions in schizophrenia: associations with self-reflectivity, symptomatology, and neurocognition. Psychiatry Res. 2010, 179(1):6-11.
34. Gold S., Arndt S., Nopoulos P., O'Leary D.S., Andreasen N.C. Longitudinal study of cognitive function in first-episode and recent-onset schizophrenia. Am. J. Psychiatry 1999, 156(9):1342-1348.
35. Harvey P.D., Koren D., Reichenberg A., Bowie C.R. Negative symptoms and cognitive deficits: what is the nature of their relationship?. Schizophr. Bull. 2006, 32(2):250-258.
36. Harvey P.O., Lee J., Horan W.P., Ochsner K., Green M.F. Do patients with schizophrenia benefit from a self-referential memory bias?. Schizophr. Res. 2011, 127:171-177.
37. Heckers S., Goff D., Schacter D.L., Savage C.R., Fischman A.J., Alpert N.M., Rauch S.L. Functional imaging of memory retrieval in deficit vs nondeficit schizophrenia. Arch. Gen. Psychiatry 1999, 56(12):1117-1123.
38. Heydebrand G., Weiser M., Rabinowitz J., Hoff A.L., DeLisi L.E., Csernansky J.G. Correlates of cognitive deficits in first episode schizophrenia. Schizophr. Res. 2004, 68(1):1-9.
39. Hoff A.L., Svetina C., Shields G., Stewart J., DeLisi L.E. Tenyear longitudinal study of neuropsychological functioning subsequent to a first episode of schizophrenia. Schizophr. Res. 2005, 78(1):27-34.
40. Hovington C.L., Lepage M. Neurocognition and neuroimaging of persistent negative symptoms of schizophrenia. Expert. Rev. Neurother. 2012, 12(1):53-69.
41. Hovington C.L., Bodnar M., Joober R., Malla A.K., Lepage M. Identifying persistent negative symptoms in first episode psychosis. BMC Psychiatry 2012, 12(1):224.
42. Hughes C., Kumari V., Soni W., Das M., Binneman B., Drozd S., O'Neil S., Mathew V., Sharma T. Longitudinal study of symptoms and cognitive function in chronic schizophrenia. Schizophr. Res. 2003, 59(2-3):137-146.
43. Keefe R.S.E., Bilder R.M., Harvey P.D., Davis S.M., Palmer B.W., Gold J.M., Meltzer H.Y., Green M.F., Miller D.D., Canive J.M., Adler L.W., Manschreck T.C., Swartz M., Rosenheck R., Perkins D.O., Walker T.M., Stroup T.S., McEvoy J.P., Lieberman J.A. Baseline neurocognitive deficits in the CATIE schizophrenia trial. Neuropsychopharmacology 2006, 31(9):2033-2046.
44. Killgore W.D.S., Rosso I.M., Gruber S.A., Yurgelun-Todd D.A. Amygdala volume and verbal memory performance in schizophrenia and bipolar disorder. Cogn. Behav. Neurol. 2009, 22(1):28-37.
45. Kirkpatrick B., Fenton W.S., Carpenter W.T., Marder S.R. The NIMH-MATRICS consensus statement on negative symptoms. Schizophr. Bull. 2006, 32(2):214-219.
46. Kraepelin E. Dementia Praecox and Paraphrenia 1971, Robert E Krieger Publishing, Huntington, NY.
47. Leeson V.C., Barnes T.R.E., Harrison M., Matheson E., Harrison I., Mutsatsa S.H., Ron M.A., Joyce E.M. The relationship between IQ, memory, executive function, and processing speed in recent-onset psychosis: 1-year stability and clinical outcome. Schizophr. Bull. 2010, 36(2).
48. Lencz T., Smith C.W., McLaughlin D., Auther A., Nakayama E., Hovey L., Cornblatt B.A. Generalized and specific neurocognitive deficits in prodromal schizophrenia. Biol. Psychiatry 2006, 59(9):863-871.
49. Lepage M., Buchy L., Bodnar M., Bertrand M.C., Joober R., Malla A. Cognitive insight and verbal memory in first episode of psychosis. Eur. Psychiatry 2008, 23(5):368-374.
50. Lepage M., Pelletier M., Achim A., Montoya A., Menear M., Lal S. Parietal cortex and episodic memory retrieval in schizophrenia. Psychiatry Res. 2011, 182:191-199.
51. Malaspina D., Harkavy-Friedman J., Corcoran C., Mujica-Parodi L., Printz D., Gorman J.M., Van Heertum R. Resting neural activity distinguishes subgroups of schizophrenia patients. Biol. Psychiatry 2004, 56(12):931-937.
52. Malla A.K., Takhar J.J., Norman R.M.G., Manchanda R., Cortese L., Haricharan R., Verdi M., Ahmed R. Negative symptoms in first episode non-affective psychosis. Acta Psychiatr. Scand. 2002, 105(6):431-439.
53. Malla A., Norman R., McLean T., Scholten D., Townsend L. A Canadian programme for early intervention in non-affective psychotic disorders. Aust. N. Z. J. Psychiatry 2003, 37(4):407-413.
54. Malla A.K., Norman R.M., Takhar J., Manchanda R., Townsend L., Scholten D., Haricharan R. Can patients at risk for persistent negative symptoms be identified during their first episode of psychosis?. J. Nerv. Ment. Dis. 2004, 192(7):455-463.
55. McGurk S.R., Moriarty P.J., Harvey P.D., Parrella M., White L., Davis K.L. The longitudinal relationship of clinical symptoms, cognitive functioning, and adaptive life in geriatric schizophrenia. Schizophr. Res. 2000, 42(1):47-55.
56. Milev P., Ho B.C., Arndt S., Andreasen N.C. Predictive values of neurocognition and negative symptoms on functional outcome in schizophrenia: a longitudinal first-episode study with 7-year follow-up. Am. J. Psychiatry 2005, 162(3):495-506.
57. Miller D.C. Handbook for Research Design and Social Measurement 1991, Sage Publications, Newbury Park, CA. 5th edition.
58. Mueser K.T., Sayers S.L., Schooler N.R., Mance R.M., Haas G.L. A multisite investigation of the reliability of the scale for the assessment of negative symptoms. Am. J. Psychiatry 1994, 151(10):1453-1462.
59. Nuechterlein K.H., Barch D.M., Gold J.M., Goldberg T.E., Green M.F., Heaton R.K. Identification of separable cognitive factors in schizophrenia. Schizophr. Res. 2004, 72(1):29-39.
60. O'Sullivan M., Guilford J.P. Four Factor Tests of Social Intelligence (Behavioural Cognition): Manual of Instructions and Interpretations Sheridan Psychological Services, Inc, Orange, CA 1976.
61. O'Driscoll G.A., Florencio P.S., Gagnon D., Wolff A.L.V., Benkelfat C., Mikula L., Lal S., Evans A.C. Amygdala-hippocampal volume and verbal memory in first-degree relatives of schizophrenic patients. Psychiatry Res. Neuroimaging 2001, 107(2):75-85.
62. Oldfield R.C. The assessment and analysis of handedness: the Edinburgh inventory. Neuropsychologia 1971, 9(1):97-113.
63. O'Leary D.S., Flaum M., Kesler M.L., Flashman L.A., Arndt S., Andreasen N.C. Cognitive correlates of the negative, disorganized, and psychotic symptom dimensions of schizophrenia. J. Neuropsychiatry Clin. Neurosci. 2000, 12(1):4-15.
64. Peralta V., Cuesta M.J. Dimensional structure of psychotic symptoms: an item-level analysis of SAPS and SANS symptoms in psychotic disorders. Schizophr. Res. 1999, 38(1):13-26.
65. Pukrop R., Schultze-Lutter F., Ruhrmann S., Brockhaus-Dumke A., Tendolkar I., Bechdolf A., Matuschek E., Klosterkotter J. Neurocognitive functioning in subjects at risk for a first episode of psychosis compared with first- and multiple-episode schizophrenia. J. Clin. Exp. Neuropsychol. 2006, 28(8):1388-1407.
66. Putnam K.M., Harvey P.D. Cognitive impairment and enduring negative symptoms: a comparative study of geriatric and nongeriatric schizophrenia patients. Schizophr. Bull. 2000, 26(4):867-878.
67. Qiu A.Q., Tuan T.A., Woon P.S., Abdul-Rahman M.F., Graham S., Sim K. Hippocampal-cortical structural connectivity disruptions in schizophrenia: an integrated perspective from hippocampal shape, cortical thickness, and integrity of white matter bundles. NeuroImage 2010, 52(4):1181-1189.
68. Ragland J.D., Blumenfeld R.S., Ramsay I.S., Yonelinas A., Yoon J., Solomon M., Carter C.S., Ranganath C. Neural correlates of relational and item-specific encoding during working and long-term memory in schizophrenia. NeuroImage 2012, 59(2):1719-1726.
69. Rajarethinam R., DeQuardo J.R., Miedler J., Arndt S., Kirbat R., Brunberg J.A., Tandon R. Hippocampus and amygdala in schizophrenia: assessment of the relationship of neuroanatomy to psychopathology. Psychiatry Res. Neuroimaging 2001, 108(2):79-87.
70. Reitan R.M. Train Making Test: Manual for Administration and Scoring Reitan Neuropsychological Laboratory 1992.
71. Rund B.R., Melle I., Friis S., Larsen T.K., Midboe L.J., Opjordsmoen S., Simonsen E., Vaglum P., McGlashan T. Neurocognitive dysfunction in first-episode psychosis: correlates with symptoms, premorbid adjustment, and duration of untreated psychosis. Am. J. Psychiatry 2004, 161(3):466-472.
72. Sayers S.L., Curran P.J., Mueser K.T. Factor structure and construct validity of the scale for the assessment of negative symptoms. Psychol. Assess. 1996, 8(3):269-280.
73. Schuepbach D., Keshavan M.S., Kmiec J.A., Sweeney J.A. Negative symptom resolution and improvements in specific cognitive deficits after acute treatment in first-episode schizophrenia. Schizophr. Res. 2002, 53(3):249-261.
74. Schuepbach D., Hill S.K., Sanders R.D., Hell D., Keshavan M.S., Sweeney J.A. Early treatment induced improvement of negative symptoms predicts cognitive functioning in treatment naive first episode schizophrenia: a 2-year followup. Schizophr. Bull. 2004, 30(4):837-848.
75. Sigmundsson T., Suckling J., Maier M., Williams S., Bullmore E., Greenwood K., Fukuda R., Ron M., Toone B. Structural abnormalities in frontal, temporal, and limbic regions and interconnecting white matter tracts in schizophrenic patients with prominent negative symptoms. Am. J. Psychiatry 2001, 158(2):234-243.
76. Stauffer V.L., Song G.C., Kinon B.J., Ascher-Svanum H., Chen L., Feldman P.D., Conley R.R. Responses to antipsychotic therapy among patients with schizophrenia or schizoaffective disorder and either predominant or prominent negative symptoms. Schizophr. Res. 2012, 134(2-3):195-201.
77. Stolar N., Berenbaum H., Banich M.T., Barch D. Neuropsychological correlates of alogia and affective flattening in schizophrenia. Biol. Psychiatry 1994, 35(3):164-172.
78. Szeszko P.R., Robinson D.G., Ashtari M., Vogel J., Betensky J., Sevy S., Ardekani B.A., Lencz T., Malhotra A.K., McCormack J., Miller R., Lim K.O., Gunduz-Bruce H., Kane J.M., Bilder R.M. Clinical and neuropsychological correlates of white matter abnormalities in recent onset schizophrenia. Neuropsychopharmacology 2008, 33(5):976-984.
79. Vaz S.A.M., Heinrichs R.W. Schizophrenia and memory impairment: evidence for a neurocognitive subtype. Psychiatry Res. 2002, 113(1-2):93-105.
80. Ventura J., Hellemann G.S., Thames A.D., Koellner V., Nuechterlein K.H. Symptoms as mediators of the relationship between neurocognition and functional outcome in schizophrenia: a meta-analysis. Schizophr. Res. 2009, 113(2-3):189-199.
81. Voineskos A.N., Foussias G., Lerch J., Felsky D., Remington G., Rajji T.K., Lobaugh N., Pollock B.G., Mulsant B.H. Neuroimaging evidence for the deficit subtype of schizophrenia. JAMA Psychiatry 2013, 1-9.
82. Wechsler D. Wechsler Adult Intelligence Scale 1997, The Psychological Corporation, San Antonio, TX. 3rd ed.
83. Wechsler D. Wechsler Memory Scale 1997, The Psychological Corporation, New York. 3rd ed.
84. Wechsler D. Wechsler Adult Intelligence Scale 1997, The Psychological Corporation.
85. Woodberry K.A., Seidman L.J., Giuliano A.J., Verdi M.B., Cook W.L., McFarlane W.R. Neuropsychological profiles in individuals at clinical high risk for psychosis: relationship to psychosis and intelligence. Schizophr. Res. 2010, 123(2-3):188-198.
86. Woods S.W. Chlorpromazine equivalent doses for the newer atypical antipsychotics. J. Clin. Psychiatry 2003, 64(6):663-667.
87. Zhou F.C., Xiang Y.T., Wang C.Y., Dickerson F., Au R.W.C., Zhou J.J., Zhou Y., Shum D.H.K., Chiu H.F.K., Man D., Lee E.H.M., Yu X., Chan R.C.K., Ungvari G.S. Characteristics and clinical correlates of prospective memory performance in first-episode schizophrenia. Schizophr. Res. 2012, 135(1-3):34-39.